Diagnosis of gastric carcinoma in Japan and western countries

Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma.

Gut·2007

Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.

Alimentary pharmacology & therapeutics·2007

Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia.

Endoscopy·2007

Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.

Endoscopy·2006

Clinical course of collagenous colitis over a period of 10 years.

Zeitschrift fur Gastroenterologie·2006

Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2006

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Emerging role of nuclear phospholipase C-β1 in lung cancer.

European journal of histochemistry : EJH·2026

Ultrasound-guided core-needle biopsy for the diagnosis of calciphylaxis in a peritoneal dialysis patient.

Journal of nephrology·2026

The PCOS-to-PMOS shift in the broader history of nomenclature changes and its uncertain impact on clinical practice.

Acta obstetricia et gynecologica Scandinavica·2026

Quercetin reverses the breast cancer-promoting effects of depression by targeting PPARγ.

Chinese journal of natural medicines·2026

Cutaneous clues: Malignant acanthosis nigricans and tripe palms as first signs of recurrent endometrial carcinoma.

Taiwanese journal of obstetrics & gynecology·2026

Human papillomavirus-independent, TP53 Wild-type Vulvar Intraepithelial Neoplasia and Its Mimics.

Surgical pathology clinics·2026

Diagnosis of gastric carcinoma in Japan and western countries

Related Experiment Videos

Related Concept Videos

Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma.

Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.

Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia.

Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.

Clinical course of collagenous colitis over a period of 10 years.

Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Emerging role of nuclear phospholipase C-β1 in lung cancer.

Ultrasound-guided core-needle biopsy for the diagnosis of calciphylaxis in a peritoneal dialysis patient.

The PCOS-to-PMOS shift in the broader history of nomenclature changes and its uncertain impact on clinical practice.

Quercetin reverses the breast cancer-promoting effects of depression by targeting PPARγ.

Cutaneous clues: Malignant acanthosis nigricans and tripe palms as first signs of recurrent endometrial carcinoma.

Human papillomavirus-independent, TP53 Wild-type Vulvar Intraepithelial Neoplasia and Its Mimics.

Diagnosis of gastric carcinoma in Japan and western countries

Related Experiment Videos

Related Concept Videos

Related Articles